Navigation Links
American Scientific Resources Inc. Opens Shanghai Location
Date:11/25/2009

WESTON, Fla., Nov. 25 /PRNewswire-FirstCall/ -- American Scientific Resources Inc. (Pink Sheets: ASFX) ("the Company") is pleased to announce that they have opened a regional marketing and production management office in Shanghai, China.

ASR has been able to secure a location abroad, providing an essential gateway for the development and production of current and future health and safety products for children and adults to be distributed and sold globally. Currently the company houses inventory in the state of Ohio where they will also be able to do sub component manufacturing.

Mr. Jason Roth, Senior VP, recently visited China, and attended the premier medical conference MEDICA, along with Dr. Christopher Tirotta, CEO, to solidify plans for expansion. Mr. Roth comments, "Not only will this venture be cost effective for product development and construction but it will also give us a futuristic edge on the various new technologies up and coming in order to position ourselves as a global leader."

Dr. Tirotta commented, "By making it easier for end users and the professional market across the globe to benefit from the unique products we sell, and the products we hope to develop and distribute, we expect the power of numbers to increase the chances of fulfilling one of the many goals of the company which is to become a household name associated with trust and quality."

About American Scientific Resources, Inc.

American Scientific Resources, Inc. is the parent company for wholly-owned subsidiary, Kidz-Med, Inc. The Company's objective is to create intellectual property, as well as to locate and acquire innovative health and safety products and to introduce and promote them to the North American and Global consumer and professional healthcare market. More information about the Company, including
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting
2. Neonatal Scenarios Developed in Partnership with the American Academy of Pediatrics (AAP), Utilize the NRP Curriculum to Advance Newborn Care
3. American Oriental Bioengineering Reports Third Quarter 2009 Financial Results
4. American Heart Association Late-Breaking Clinical Trial Report: New Reversible Oral Drug Reduces Cardiac Events in Primary PCI Patients
5. American Heart Association Late-Breaking Clinical Trial Report: New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint, but Did Reduce Death and Stent Thrombosis
6. Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference
7. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
8. VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting
9. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
10. American Oriental Bioengineering to Report Third Quarter 2009 Financial Results on November 16, 2009
11. ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015  ResMed (NYSE: RMD ... definitive agreement to acquire Curative Medical, a ... sleep-disordered breathing medical devices and accessories. ... with ResMed,s global leadership in sleep and respiratory medicine, ... China suffering from sleep-disordered breathing ...
(Date:7/30/2015)... Calif. , July 30, 2015  EP ... /Alcon executives have recently contacted the Company about ... begin as early as Monday, August 3, 2015.  ... quoted as saying that the coming electronic contact ... of dollars over the next several years.  Novartis ...
(Date:7/30/2015)...  Amgen (NASDAQ: AMGN ) today announced ... Key results include: , Total revenues increased ... to $5,370 million, with 6 percent product sales ... Prolia ® (denosumab), Sensipar ® (cinacalcet), ... (denosumab). Unfavorable changes in foreign exchange rates impacted ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23
... LIONVILLE, Pa., Dec. 16, 2010 West Pharmaceutical Services, Inc. (NYSE: ... has approved payment of the first-quarter 2011 cash dividend of $0.17 ... to shareholders of record on January 19, 2011. ... of components and systems for injectable drug delivery, including stoppers and ...
... (Nasdaq: HSKA, "Heska" or the "Company"), announced today that ... Forever, has been awarded $25,000 as the grand prize ... (Logo: http://photos.prnewswire.com/prnh/20000622/HESKALOGO) Helping low-income ... their pets for as long as possible, Pets Forever ...
Cached Medicine Technology:Heska Corporation Awards $25,000 Grand Prize to Pets Forever 2
(Date:7/31/2015)... ... 31, 2015 , ... In the most recent testosterone lawsuit news ... District of Illinois, Androgel testosterone attorneys report that a “Mini Status Conference” was held ... recording the minutes of the status conference, which was held that day, according to ...
(Date:7/31/2015)... ... July 31, 2015 , ... People love to feel ... insurance, where price is an important factor to clients when choosing to purchase ... offers the Preferred Producer Multi-Life Discount program, where advisers pass savings onto their ...
(Date:7/30/2015)... ... July 31, 2015 , ... Reduce ... or More, **Presented by FDAnews and Ginette M. Collazo, Inc.**, Sept. 16-17, 2015 ... veteran of helping drug, biologic and device firms reduce manufacturing errors by 50 ...
(Date:7/30/2015)... ... 2015 , ... As more hospitals across the country see the value in ... challenge. Because of growing competition, it is more important than ever to market ... The team at Wound Care Advantage has found that while many hospitals ...
(Date:7/30/2015)... ... July 30, 2015 , ... Women's dating ... Lines ." It's for women interested in improving their love lives using specific ... which officially launched to the public early this morning, has drawn praise from ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 2Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 3Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 4Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2
... Steven Reinberg HealthDay Reporter , WEDNESDAY, Oct. 5 (HealthDay ... introduced the world to personal computers, then the iPod, the iPhone ... cancer. He was 56. "Apple has lost ... amazing human being," the company said in a statement it posted ...
... of strategies released today by the Commonwealth Fund Commission ... how the U.S. health care system serves vulnerable populationsthose ... of racial and ethnic minority groups. According to ... Achieve High Performance Health Care for Vulnerable Populations, closing ...
... AMHERST, Mass. -- New research based on post-hospital arrival ... adjusting for differences in injury severity, gun use, and ... assault, African-Americans have a significantly higher overall post-scene of ... by Anthony R. Harris, emeritus professor of sociology at ...
... 12 or older are estimated to have driven under the ... a 2009 National Survey on Drug Use and Health. While ... its role in causing crashes has remained in question. To ... of a car accident, researchers at Columbia University did a ...
... and run and how their knees look in an MRI ... decades in advance whether they will develop osteoarthritis, the common ... the time they reach the age of 70. Doctors ... scan and tell you definitively whether or not they will ...
... (HealthDay News) -- Technology that directly oxygenates the blood reduced ... by the H1N1 flu virus, a new British study shows. ... they noted that debate continues about the use of the ... called extracorporeal membrane oxygenation, which oxygenates the blood. It,s used ...
Cached Medicine News:Health News:Steve Jobs, Visionary Leader of Apple Inc., Dies at 56 2Health News:Steve Jobs, Visionary Leader of Apple Inc., Dies at 56 3Health News:Strategy for improving health care for uninsured, low-income, and minorities in the US 2Health News:Strategy for improving health care for uninsured, low-income, and minorities in the US 3Health News:Strategy for improving health care for uninsured, low-income, and minorities in the US 4Health News:Strategy for improving health care for uninsured, low-income, and minorities in the US 5Health News:Researchers find race disparity in post-hospital arrival homicide deaths at trauma centers 2Health News:Marijuana use may double the risk of accidents for drivers 2Health News:$6.3 million center at UCSF and UC Davis seeks ways to diagnose and prevent osteoarthritis 2Health News:$6.3 million center at UCSF and UC Davis seeks ways to diagnose and prevent osteoarthritis 3Health News:Oxygenating Blood of Hospitalized H1N1 Flu Patients Saved Lives: Study 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: